Implementing the number needed to harm in clinical practice: risk of myocardial infarction in HIV‐1‐infected patients treated with abacavir
Justyna Kowalska(Medical University of Warsaw), Jens Lundgren(Centre of Excellence for Health, Immunity and Infections), Ole Kirk(University of Copenhagen), Nina Friis‐Møller(University of Copenhagen), Amanda Mocroft(University of Copenhagen), Peter Reiss(Amsterdam Institute for Global Health and Development), L Høj(University of Copenhagen), Ian Weller(University College London)
Cited by 15
Related Papers
Antiretroviral Treatment of Adult HIV Infection
|JAMA|2012|2.5k
Industrial enzyme applications
|Current Opinion in Biotechnology|2002|1.5k
Decline in the AIDS and death rates in the EuroSIDA study: an observational study
|The Lancet|2003|1.2k
Antiretroviral Treatment of Adult HIV Infection
|JAMA|2008|1k